Everest Organics [EVERESTO] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Everest Organics Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Everest Organics Ltd. wins in 14 metrics, Sun Pharma Advanced Research Company Ltd. wins in 4 metrics, with 0 ties. Everest Organics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Everest Organics Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 52.29 -13.65 Everest Organics Ltd.
Price-to-Book Ratio 3.71 -13.55 Everest Organics Ltd.
Debt-to-Equity Ratio 68.11 -1.21 Everest Organics Ltd.
PEG Ratio -0.71 -11.15 Everest Organics Ltd.
EV/EBITDA 18.13 -22.27 Everest Organics Ltd.
Profit Margin (TTM) 3.08% -53.22% Everest Organics Ltd.
Operating Margin (TTM) 5.30% -700.71% Everest Organics Ltd.
EBITDA Margin (TTM) 5.30% N/A N/A
Return on Equity -1.84% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) -0.57% -102.08% Everest Organics Ltd.
Free Cash Flow (TTM) $-108.03M $-3.71B Everest Organics Ltd.
1-Year Return -37.06% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.42 87.98 Everest Organics Ltd.
Enterprise Value $3.19B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.69 95.73 Everest Organics Ltd.
Gross Profit Margin (TTM) 38.71% -59.53% Everest Organics Ltd.
Revenue per Share (TTM) $197 $2 Everest Organics Ltd.
Earnings per Share (Diluted) $5.29 $-8.25 Everest Organics Ltd.
Beta (Stock Volatility) 0.43 0.19 Sun Pharma Advanced Research Company Ltd.

Everest Organics Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

EVERESTO
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Everest Organics Ltd.6.20%-10.00%-11.08%-15.32%-43.80%-53.20%
Sun Pharma Advanced Research Company Ltd.2.14%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Everest Organics Ltd.-37.06%167.84%-27.25%931.92%6,868.83%6,868.83%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Everest Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricEVERESTOSPARC
Market Information
Market Cap i₹2.64B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i5,4822,401,062
90 Day Avg. Volume i9,1992,083,443
Last Close₹248.50₹212.97
52 Week Range₹197.00 - ₹536.40₹108.00 - ₹248.75
% from 52W High-53.67%-14.38%
All-Time High₹536.40 (Jan 02, 2026)₹875.00 (Apr 24, 2006)
% from All-Time High-53.67%-75.66%
Growth Metrics
Quarterly Revenue Growth0.02%-0.43%
Quarterly Earnings Growth-0.69%-0.43%
Financial Health
Profit Margin (TTM) i0.03%-0.53%
Operating Margin (TTM) i0.05%-7.01%
Return on Equity (TTM) i-0.02%1.58%
Debt to Equity (MRQ) i68.11-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹74.65₹-10.63
Cash per Share (MRQ)₹1.08₹0.03
Operating Cash Flow (TTM) i₹38.10M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹-12,903,000₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00N/A

Valuation & Enterprise Metrics Analysis: Everest Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricEVERESTO (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i52.29-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.71-11.15
Price to Sales (TTM) i1.4287.98
Price to Book (MRQ) i3.71-13.55
Market Capitalization
Market Capitalization i₹2.64B₹46.75B
Enterprise Value i₹3.19B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.6995.73
Enterprise to EBITDA i18.13-22.27
Risk & Other Metrics
Beta i0.430.19
Book Value per Share (MRQ) i₹74.65₹-10.63

Financial Statements Comparison: Everest Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEVERESTO (2025)SPARC (2025)
Revenue/Sales i1.59B717.66M
Cost of Goods Sold i985.43M1.10B
COGS % of Revenue i61.8%153.2%
Gross Profit i609.36M-381.94M
Gross Margin i38.2%-53.2%
Research & Development i8.29MN/A
Operating Income (EBIT) i23.83M-3.34B
Operating Margin i1.5%-465.5%
EBITDA i78.09M-3.23B
EBITDA Margin i4.9%-450.0%
Pre-Tax Income i-32.43M-3.43B
Pre-Tax Income % of Revenue i-2.0%-477.6%
Income Tax i-19.52M-2.72M
Income Tax % of Revenue i-1.2%-0.4%
Net Income (Profit) i-12.90M-3.43B
Profit Margin i-0.8%-477.3%

Balance Sheet & Liquidity Metrics

MetricEVERESTO (2025)SPARC (2025)
Cash & Equivalents i60.92M19.64M
Total Current Assets i1.48B261.97M
Total Current Assets % of Revenue i92.7%36.5%
Total Current Liabilities i1.40B3.74B
Total Current Liabilities % of Revenue i87.7%521.5%
Long-Term Debt i91.98M1.07B
Long-Term Debt % of Revenue i5.8%149.0%
Total Shareholders Equity i699.47M-2.17B
Retained Earnings i312.18M-23.22B
Retained Earnings % of Revenue i19.6%-3,235.0%
Property, Plant & Equipment i483.39M178.02M

Cash Flow Statement Comparison

MetricEVERESTO (2025)SPARC (2025)
Operating Cash Flow i38.10M-3.48B
Operating Cash Flow % of Revenue i2.4%-485.5%
Capital Expenditures i-35.77M-97.45M
Free Cash Flow i-108.03M-3.71B
FCF Margin i-6.8%-516.4%
Debt Repayment iN/A-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricEVERESTOSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i9.71M324.52M
Float Shares i978,95891.32M
% Held by Insiders i76.90%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i23.10%24.48%

Dividend Analysis & Yield Comparison: Everest Organics Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricEVERESTOSPARC
Last 12-Month Dividend i₹0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.17N/A
3-Year Avg Dividend Yield i0.35%N/A
3-Year Total Dividends i₹0.50N/A
Ex-Dividend DateSep 15, 2022N/A